← Product Code [LJB](/submissions/MI/subpart-d%E2%80%94serological-reagents/LJB) · K891990

# RUBEOLA IGG CLIN-ELISA TEST SYSTEM, CAT. #4600 (K891990)

_Clinical Sciences, Inc. · LJB · Jun 15, 1989 · Microbiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/LJB/K891990

## Device Facts

- **Applicant:** Clinical Sciences, Inc.
- **Product Code:** [LJB](/submissions/MI/subpart-d%E2%80%94serological-reagents/LJB.md)
- **Decision Date:** Jun 15, 1989
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.3520
- **Device Class:** Class 1
- **Review Panel:** Microbiology

## Regulatory Identification

Rubeola (measles) virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubeola virus in serum. The identification aids in the diagnosis of measles and provides epidemiological information on the disease. Measles is an acute, highly infectious disease of the respiratory and reticuloendothelial tissues, particularly in children, characterized by a confluent and blotchy rash.

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/LJB/K891990](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/LJB/K891990)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com